AMAline Fontanella Maciel

Aline Fontanella Maciel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aline Fontanella Maciel has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Equidae pythiosis in Brazil and the world: a systematic review of the last 63 years (1960–2023)

    by Daniela Isabel Brayer Pereira, Sônia Avila Botton, Lara Baccarin Ianiski, Caroline Quintana Braga, Aline Fontanella Maciel, Luíze Garcia Melo, Cristina Gomes Zambrano, Fábio Raphael Pascoti Bruhn, Janio Morais Santurio

    This systematic review compiles reports of clinical pythiosis in horses, mules and donkeys from 1960 to 2023 worldwide, focusing on Brazil. We searched databases and included 71 articles detailing clinical characteristics, geographic distribution, epidemiology, diagnostic methods, therapies, and outcomes. The results showed that publications on equine pythiosis have significantly increased since 2010. Brazil reported the highest incidence, comprising 55% of cases, predominantly in the southern, northeastern, and central-western regions during summer and autumn. Cutaneous pythiosis was the most prevalent form, generally presenting as single lesions in the appendicular region, and affected females more than males. Diagnosis typically involved histopathology, used alone or with other methods. Various treatments have been employed, with surgery, often combined with chemotherapy and immunotherapy, being the most common. Notably, 80.84% of treated animals recovered, highlighting the effectiveness of these therapies in enhancing survival rates. The limitations of the study included the lack of data in published case reports, which made it difficult to collect and calculate epidemiological data. Additionally, we recognize that pythiosis in Brazil is underreported, since this disease does not have mandatory notification and several cases are not registered and/or reported in the literature. Lastly, it is hypothesized that equid pythiosis may be more widespread than currently known, and its real occurrence in Brazil remains uncertain.


  • Pythium insidiosum: In vitro oomicidal evaluation of telithromycin and interactions with azithromycin and amorolfine hydrochloride

    by Lara Baccarin Ianiski, Aline Fontanella Maciel, Ana Carolina Nolasco Colla, Caroline Quintana Braga, Luis Antônio Sangioni, Mahendra Pal, Daniela Isabel Brayer Pereira, Janio Morais Santurio, Sônia de Avila Botton


  • Open Access

    Promising use of nanotechnology in Pythium insidiosum: a systematic review

    by Lara Baccarin Ianiski, Aline Fontanella Maciel, Caroline Quintana Braga, Carla Weiblen, Daniela Isabel Brayer Pereira, Luís Antônio Sangioni, Janio Morais Santurio, Luciana Pötter, Sônia de Avila Botton

    The aquatic oomycete Pythium insidiosum is an emerging pathogen highly relevant in human and veterinary medicine and an etiologic agent of pythiosis, a disease of worldwide distribution mainly affecting horses, dogs, and humans, presenting cutaneous, subcutaneous, ocular, gastrointestinal, and systemic forms. The available therapeutic methods to treat this disease and its forms are not entirely effective, thus highlighting the need to investigate the forms of treatments with better efficacy, such as compounds from different pharmacological classes, compounds of natural origin, and new technological alternatives, including nanotechnology. Therefore, this study evaluated scientific publications regarding the use of nanotechnology in P. insidiosum treatment. For this, a systematic literature review, was carried out on articles published from 2010 to 2022 on the LILACS, MEDLINE, Google Scholar, PubMed, and SciELO databases using the descriptors ‘Pythium insidiosum,’ ‘pythiosis,’ ‘nanotechnology,’ ‘nanoparticles,’ ‘nanoemulsion,’ and ‘treatment.’ We reported 162 articles for the researched theme; although, only four studies were included because they met the criteria established herein. A meta-analysis was used for the statistical analysis of the data obtained in vitro studies, and we reported the use of nanotechnology can be a promising alternative in developing antimicrobial compounds with anti-P. insidiosum activity. Nevertheless, additional research is needed to verify the potential use of this technology in clinical therapy against P. insidiosum infections.


  • Oomicidal activity of polypyrrole nanoparticles against Pythium insidiosum

    by Lara Baccarin Ianiski, Aline Fontanella Maciel, Carla Weiblen, Paula Cristina Stibbe, Helinando Pequeno de Oliveira, Mateus Matiuzzi da Costa, Luis Antônio Sangioni, Daniela Isabel Brayer Pereira, Janio Morais Santurio, Sônia de Avila Botton

    This study evaluated in-vitro action of a new molecule, the polypyrrole nanoparticles (Ppy-NP), against Pythium insidiosum isolates using M38-A2/CLSI; the minimal inhibitory (MIC) and minimal oomicidal (MOC) concentrations were also determined. Additionally, changes in the hyphae wall of P. insidiosum CBS 575.85 treated with Ppy-NP were evaluated by scanning electron microscopy (SEM). The MIC100 and MOC for all isolates ranged from 8 to 32 μg mL−1, and the MIC90 and MIC50 were 16 μg mL−1. The SEM showed structural damage to the hyphae of P. insidisoum treated with Ppy-NP, as hyphae surfaces with less turgidity were found, thereby showing scaling and ruptures compared to the control (untreated hyphae). Our findings highlighted the anti-P. insidiosum properties of Ppy-NP proved to be a promising candidate for research using pythiosis experimental models.


  • Mefenoxam and pyraclostrobin: toxicity and in vitro inhibitory activity against Pythium insidiosum

    by P.C. Stibbe, L.B. Ianiski, C. Weiblen, A.F. Maciel, M.L. Machado, T.L. da Silveira, F.A.A. Soares, J.M. Santurio, M.P. Soares, D.I.B. Pereira, et al.

    The objective of this study is to verify in vitro susceptibility of Pythium insidiosum against the agricultural fungicides mefenoxam and pyraclostrobin and evaluate the toxicity of both compounds. Twenty-one P. insidiosum isolates were tested against mefenoxam and pyraclostrobin using the broth microdilution method. Minimum inhibitory and oomicidal concentrations for both compounds were established. Additionally, scanning electron microscopy was performed on P. insidiosum hyphae treated with the sublethal concentration of each fungicide. The toxicity of the compounds was evaluated in vivo Caenorhabditis elegans model. The concentration to inhibit 100% of P. insidiosum growth ranged from 0·625 to 10 μg ml−1 for mefenoxam and from 0·019 to 5 μg ml−1 for pyraclostrobin. The SEM analysis revealed changes on the surface of the hyphae treated with the fungicides, suggesting possible damage caused by these compounds. There was no evidence of toxicity in vivo models. Mefenoxam and pyraclostrobin did not show toxicity at the doses evaluated and have inhibitory effects on the pathogenic oomycete P. insidiosum. However, further evaluations of their pharmacokinetics and toxicity in different animal species and possible pharmacological interactions are necessary to infer a possible use in the clinical management of pythiosis.